Cargando…

Therapeutic drug monitoring in children and adolescents with schizophrenia and other psychotic disorders using risperidone

Risperidone is commonly used to treat different psychiatric disorders worldwide. Knowledge on dose–concentration relationships of risperidone treatment in children and adolescents with schizophrenia or other psychotic disorders is, however, scarce and no age-specific therapeutic ranges have been est...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taurines, R., Fekete, S., Preuss-Wiedenhoff, A., Warnke, A., Wewetzer, C., Plener, P., Burger, R., Gerlach, M., Romanos, M., Egberts, K. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2022
Materias:	Psychiatry and Preclinical Psychiatric Studies - Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188514/ https://www.ncbi.nlm.nih.gov/pubmed/35303169 http://dx.doi.org/10.1007/s00702-022-02485-6

Ejemplares similares

Value of a web-based pediatric drug information system to prevent serious adverse drug reactions in child and adolescent psychiatry
por: Fekete, Stefanie, et al.
Publicado: (2022)

Altered urinary tetrahydroisoquinoline derivatives in patients with Tourette syndrome: reflection of dopaminergic hyperactivity?
por: Capetian, Philipp, et al.
Publicado: (2020)

Regional brain volumes in brief psychotic disorder
por: Li, Hua, et al.
Publicado: (2020)

Internet-based cognitive behavioral therapy in children and adolescents with obsessive compulsive disorder: a feasibility study
por: Hollmann, Karsten, et al.
Publicado: (2021)

Betrayed by the nervous system: a comparison group study to investigate the ‘unsafe world’ model of selective mutism
por: Melfsen, Siebke, et al.
Publicado: (2021)

Factor structure and internal consistency of the Clinical Assessment Interview for Negative Symptoms (CAINS) on a sample of persons with psychotic disorders in Bosnia and Herzegovina
por: Kulenović, Alma Džubur, et al.
Publicado: (2021)

Correction to: Estimation of a preliminary therapeutic reference range for children and adolescents with tic disorders treated with tiapride
por: Fekete, Stefanie, et al.
Publicado: (2021)

Estimation of a preliminary therapeutic reference range for children and adolescents with tic disorders treated with tiapride
por: Fekete, Stefanie, et al.
Publicado: (2020)

Serious Adverse Drug Reactions to Antipsychotics in Minors with Multiple Disabilities: Preventability and Potential Cost Savings by Therapeutic Drug Monitoring
por: Fekete, Stefanie, et al.
Publicado: (2022)

Association study and a systematic meta-analysis of the VNTR polymorphism in the 3′-UTR of dopamine transporter gene and attention-deficit hyperactivity disorder
por: Grünblatt, Edna, et al.
Publicado: (2019)

Lifetime Prevalence and Correlates of Schizophrenia and Other Psychotic Disorders in Singapore
por: Subramaniam, Mythily, et al.
Publicado: (2021)

Microglia and microbiome in schizophrenia: can immunomodulation improve symptoms?
por: Juckel, Georg, et al.
Publicado: (2023)

Failed regeneration and inflammation in schizophrenia: two sides of the same coin?
por: Falkai, Peter, et al.
Publicado: (2022)

Neurodevelopmental disturbances in schizophrenia: evidence from genetic and environmental factors
por: Schmitt, Andrea, et al.
Publicado: (2022)

The Basal Forebrain Cholinergic Nuclei and Their Relevance to Schizophrenia and Other Psychotic Disorders
por: Eickhoff, Sofia, et al.
Publicado: (2022)

The neurochemical pathology of schizophrenia: post-mortem studies from dopamine to parvalbumin
por: Reynolds, Gavin P.
Publicado: (2021)

The role of neurotrophins in psychopathology and cardiovascular diseases: psychosomatic connections
por: László, Andrea, et al.
Publicado: (2019)

Genetic and environmental factors of schizophrenia and autism spectrum disorder: insights from twin studies
por: Imamura, Akira, et al.
Publicado: (2020)

Pre-frontal parvalbumin interneurons in schizophrenia: a meta-analysis of post-mortem studies
por: Kaar, Stephen J., et al.
Publicado: (2019)

Efficacy of Community Treatments for Schizophrenia and Other Psychotic Disorders: A Literature Review
por: Armijo, Julio, et al.
Publicado: (2013)

Effects of Continuing Oral Risperidone vs. Switching from Risperidone to Risperidone Long-Acting Injection on Cognitive Function in Stable Schizophrenia Patients: A Pilot Study
por: Hori, Hikaru, et al.
Publicado: (2018)

Association of FKBP5 genotype with depressive symptoms in patients with coronary heart disease: a prospective study
por: Brandt, Julia, et al.
Publicado: (2020)

Effects of add-on Celecoxib treatment on patients with schizophrenia spectrum disorders and inflammatory cytokine profile trial (TargetFlame): study design and methodology of a multicentre randomized, placebo-controlled trial
por: Strube, Wolfgang, et al.
Publicado: (2022)

Cross-national gender variations of digit ratio (2D:4D) correlate with life expectancy, suicide rate, and other causes of death
por: Lenz, Bernd, et al.
Publicado: (2017)

Association Study of KCNH7 Polymorphisms and Individual Responses to Risperidone Treatment in Schizophrenia
por: Wang, Xueping, et al.
Publicado: (2019)

Metabolic biomarkers of risperidone-induced weight gain in drug-naïve patients with schizophrenia
por: Qiu, Yuying, et al.
Publicado: (2023)

Schizophrenia, Not a Psychotic Disorder: Bleuler Revisited
por: Loch, Alexandre Andrade
Publicado: (2019)

Editorial: Case reports in schizophrenia and psychotic disorders
por: Tusconi, Massimo, et al.
Publicado: (2023)

Paul Eugen Bleuler and the origin of the term schizophrenia (SCHIZOPRENIEGRUPPE)
por: Ashok, Ahbishekh Hulegar, et al.
Publicado: (2012)

C677T Polymorphism in the MTHFR Gene Is Associated With Risperidone-Induced Weight Gain in Schizophrenia
por: Liao, Jingping, et al.
Publicado: (2020)

Effects of risperidone on psychotic symptoms and cognitive functions in 22q11.2 deletion syndrome: Results from a clinical trial
por: Latrèche, Caren, et al.
Publicado: (2022)

Risperidone Effects on Brain Dynamic Connectivity—A Prospective Resting-State fMRI Study in Schizophrenia
por: Lottman, Kristin K., et al.
Publicado: (2017)

5-HTT genotype and inertia of negative affect in adolescents and young adults from the general population
por: Ollmann, T. M., et al.
Publicado: (2022)

Therapeutic drug monitoring of atomoxetine in children and adolescents with attention-deficit/ hyperactivity disorder: a naturalistic study
por: Ruppert, Katrin, et al.
Publicado: (2022)

Metabolic derangements with olanzapine and risperidone in schizophrenia spectrum and other psychotic disorders: A 24-week prospective study
por: Rikhari, Praveen, et al.
Publicado: (2022)

Knock-out of the critical nitric oxide synthase regulator DDAH1 in mice impacts amphetamine sensitivity and dopamine metabolism
por: Kozlova, Alena A., et al.
Publicado: (2023)

Influence of EGR3 Transfection on Imaging and Behavior in Rats and Therapeutic Effect of Risperidone in Schizophrenia Model
por: Li, Guangfei, et al.
Publicado: (2020)

Causal link between thyroid function and schizophrenia: a two-sample Mendelian randomization study
por: Freuer, Dennis, et al.
Publicado: (2023)

Gay men’s stress response to a general and a specific social stressor
por: Sattler, Frank A., et al.
Publicado: (2021)

Risperidone-Associated Neuroleptic Malignant Syndrome in an Inpatient With Schizophrenia, With Successful Rechallenge and 3 Year Follow-Up
por: Chen, Ting-Ren, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_kf32o2pj0vpsuaff8bdfsk10u7